 |
 |

Analysis of p53 Gene Mutations in Keloids Using Polymerase Chain ReactionBased Single-Strand Conformational Polymorphism and DNA Sequencing
Ghassan M. Saed, PhD;
Daniel Ladin, MD;
Jennifer Olson, BS;
Xuefei Han, MS;
Zizheng Hou, MD;
David Fivenson, MD
Arch Dermatol. 1998;134:963-967.
Background Keloids are the result of a dysregulated wound healing process. They are characterized by the formation of excess scar tissue that proliferates beyond the boundaries of the original wound. Somatic mutations of p53 have been implicated as causal events in up to 50% of all human malignancies. In addition, p53 has been shown to play an important role in controlling cell proliferation and apoptosis. We hypothesize that mutations in p53 can lead to a hyperproliferative state that can result in keloid formation.
Objective To detect p53 DNA mutations in tissues and cultured fibroblasts from skin lesions of 7 patients with keloids.
Design The polymerase chain reaction followed by single-strand conformational polymorphism analysis and direct DNA sequencing were used to detect p53 gene mutations.
Setting The Department of Dermatology, Henry Ford Hospital, Detroit, Mich.
Patients Seven patients with keloids seen for routine surgical excision of their lesions. Normal DNA specimens were obtained from buccal smears and healthy skin samples from these patients.
Results Mutations in the p53 gene were identified in all patients by polymerase chain reaction followed by single-strand conformational polymorphism analysis and subsequently confirmed by DNA sequencing. A mutation in exon 5 resulting in amino acid substitution was found in 1 of the patients in keloid tissue and cultured keloid fibroblasts (codon 156, CGC CCC, arginine proline). Frameshift mutations in exons 5 and 6 caused by the insertion or deletion of a nucleotide at different positions were found in 6 patients with keloids in both keloid tissues and cultured fibroblasts. Mutations in exon 4 resulting in amino acid substitution were found in all patients in both keloid tissues and cultured fibroblasts (all in codon 72, CGC CCC, arginine proline). No p53 mutations were detected in buccal smears or cultured fibroblasts from healthy skin samples of any of the patients.
Conclusions Focal mutations in p53 may increase cell proliferation and decrease cell death in the dysregulated growth patterns that have been clinically documented. An understanding of the pattern of all growth dysregulation related to keloids may lead to new therapeutic strategies.
From the Departments of Dermatology (Drs Saed and Fivenson and Mss Olson and Han) and Plastic Surgery (Drs Ladin and Hou), Henry Ford Hospital, Detroit, Mich.
RELATED ARTICLES
p53 in Dermatology
Francis P. Gasparro
Arch Dermatol. 1998;134(8):1029-1032.
EXTRACT
| FULL TEXT
Analysis of p53 Gene Mutations in Keloids Using Polymerase Chain ReactionBased Single-Strand Conformational Polymorphism and DNA SequencingClinical Implications
Bruce Smoller
Arch Dermatol. 1998;134(8):967.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Fibroblasts cocultured with keloid keratinocytes: normal fibroblasts secrete collagen in a keloidlike manner
Lim et al.
Am. J. Physiol. Cell Physiol. 2002;283:C212-C222.
ABSTRACT
| FULL TEXT
p53 Expression in the Normal Murine Eye
Pokroy et al.
IOVS 2002;43:1736-1741.
ABSTRACT
| FULL TEXT
Clinical Genetics of Familial Keloids
Marneros et al.
Arch Dermatol 2001;137:1429-1434.
ABSTRACT
| FULL TEXT
Keloid-Derived Fibroblasts Are Refractory to Fas-Mediated Apoptosis and Neutralization of Autocrine Transforming Growth Factor-{beta}1 Can Abrogate this Resistance
Chodon et al.
Am. J. Pathol. 2000;157:1661-1669.
ABSTRACT
| FULL TEXT
THE BODY'S SKIN FRONTIER AND THE CHALLENGES OF WOUND HEALING: KELOIDS
SLAVKIN
Journal of the American Dental Association 2000;131:362-365.
FULL TEXT
Molecular therapy in ocular wound healing
CORDEIRO et al.
Br. J. Ophthalmol. 1999;83:1219-1224.
FULL TEXT
Cutaneous Wound Healing
Singer and Clark
NEJM 1999;341:738-746.
FULL TEXT
p53 in Dermatology
Gasparro
Arch Dermatol 1998;134:1029-1032.
FULL TEXT
|